Company Overview and News

 
Rox Resources to acquire Bronzewing South Gold Project in WA

2018-08-08 proactiveinvestors.com.au
Rox Resources Ltd (ASX:RXL) has acquired an option to purchase the Bronzewing South Gold Project in Western Australia from private company Carnegie Exploration Pty Ltd.
RXL EAR RXXRF

 
Echo releases Yandal study

2018-08-06 businessnews.com.au
Echo Resources has released a bankable feasibility study for its Yandal gold project in Western Australia, with the company forecasting a $39.3 million capital expenditure for the mine.
EAR

 
Echo releases Yandal BFS

2018-08-06 businessnews.com.au
Echo Resources has released a bankable feasibility study for its Yandal gold project in Western Australia, with the company forecasting a $39.3 million capital expenditure for the mine.
EAR

 
Echo Resources’ BFS confirms Yandal Gold Project is economically robust

2018-08-06 proactiveinvestors.com.au
Echo Resources Ltd’s (ASX:EAR) bankable feasibility study confirms that the Yandal Gold Project in Western Australia, 83 kilometres northeast of Leinster, has robust forecast economics.
EAR

 
Renegade Exploration reveals positive maiden gold drilling results from Coralie Jean

2018-07-30 proactiveinvestors.com.au
Renegade Exploration Ltd (ASX:RNX) has received encouraging initial results from first pass aircore drilling at the Coralie Jean Prospect within its Yandal East Gold Project in Western Australia.
EAR NST

 
Toro Energy generating gold drilling targets at Yandal project

2018-06-29 proactiveinvestors.com.au
Toro Energy Ltd (ASX:TOE) is generating gold targets for upcoming exploration, including drilling, at the Yandal project within the world-class Yandal Greenstone Belt gold district of Western Australia.
EAR TOE TOEYF

3
Renegade Exploration continues major drill program at Yandal East Gold Project

2018-06-26 proactiveinvestors.com.au
Renegade Exploration Ltd (ASX:RNX) has completed drilling at the Coralie Jean prospect within its Yandal East Gold Project in Western Australia.
EAR BKHRF NSR SCEXF NST BLK NHRNY SAR NESRF

3
Renegade Exploration trades higher as activity heats up in the Yandal Greenstone Belt

2018-06-07 proactiveinvestors.com.au
Renegade Exploration Ltd (ASX:RNX) continues to attract investors as the company's exploration plans in the world-class Yandal Greenstone Belt advance.
EAR DRG BKHRF AYR NSR SCEXF NST BLK NHRNY SAR NESRF

3
Renegade Exploration commencing maiden drill program at Yandal Greenstone Belt

2018-05-29 proactiveinvestors.com.au
Renegade Exploration Ltd (ASX:RNX) non-executive director Mark Wallace speaks to Proactive Investors about the gold exploration and development company’s imminent 20,000 to 25,000 metre aircore program at Yandal East in the world-class Yandal Greenstone Belt.
EAR NST NHRNY NESRF

3
Renegade Exploration revs up for major drilling program in premier gold country

2018-05-21 proactiveinvestors.com.au
Renegade Exploration Ltd (ASX:RNX) will get the drill bit spinning in early June targeting gold at its Yandal East project in the gold-rich Yandal Greenstone Belt of Western Australia.
EAR DRG BKHRF AYR NSR SCEXF NST BLK NHRNY SAR NESRF

3
Renegade Exploration leveraged to gold news flow from world-class Yandal Greenstone Belt

2018-05-10 proactiveinvestors.com.au
Renegade Exploration Ltd (ASX:RNX) is focused on finding another major gold project in the elephant country that is the Yandal Greenstone Belt near Wiluna in Western Australia’s North Eastern Goldfields.
EAR DRG BKHRF AYR NSR SCEXF NST BLK NHRNY SAR NESRF

1
Alloy Resources applies for new ground as it looks to emulate big players like Northern Star

2018-04-17 proactiveinvestors.com.au
Alloy Resources Limited (ASX:AYR) has applied for new ground south of the company’s Horse Well Gold Project joint venture in Western Australia.
EAR AYR NST

Related Articles

ALIM: Alimera Sciences Analysis and Research Report

2018-10-01 - Asif

Overview The following discussion and analysis should be read in conjunction with its unaudited interim condensed consolidated financial statements and the related notes that appear elsewhere in this quarterly report on Form 10-Q. This discussion contains forward-looking statements reflecting its current expectations that involve risks and uncertainties. Actual results may differ materially from those discussed in these forward-looking statements due to a number of factors, including those set forth in the section entitled “Risk Factors” in its most recent annual report on Form 10-K. For further information regarding forward-looking statements, please refer to the “Special Note Regarding Forward-Looking Statements and Projections” immediately after the index to this quarterly report on Form 10-Q. Alimera Sciences, Inc., and its subsidiaries (we or Alimera), is a pharmaceutical company that specializes in the commercialization and development of prescription ophthalmic pharma...

DMPI: DelMar Pharmaceuticals Analysis and Research Report

2018-09-25 - Asif

Background DelMar Pharmaceuticals, Inc. is a clinical stage drug development company with a focus on the treatment of cancer. The company's mission is to benefit patients and create shareholder value by developing and commercializing anti-cancer therapies for patients whose tumors exhibit features that make them resistant to, or unlikely to respond to, currently available therapies, particularly for orphan cancer indications where patients have failed, or are unlikely to respond to, currently available therapy. DelMar Pharmaceuticals is developing VAL-083, a novel, DNA-targeting agent, for the treatment of glioblastoma multiforme (“GBM”) and potentially other solid tumors, including ovarian cancer. VAL-083 is a first-in-class, DNA-targeting chemotherapeutic that demonstrated activity against a range of tumor types in prior Phase 1 and Phase 2 clinical studies sponsored by the US National Cancer Institute (“NCI”). The company's recent research has highlighted the opportunit...

RIGL: Rigel Pharmaceuticals Analysis and Research Report

2018-09-18 - Asif

Overview Rigel Pharmaceuticals is a biotechnology company dedicated to discovering, developing and providing novel small molecule drugs that significantly improve the lives of patients with immune and hematologic disorders, cancer and rare diseases. The company's pioneering research focuses on signaling pathways that are critical to disease mechanisms. The company's first FDA-approved product is TAVALISSE™ (fostamatinib disodium hexahydrate), an oral spleen tyrosine kinase (SYK) inhibitor, for the treatment of adult patients with chronic immune thrombocytopenia who have had an insufficient response to a previous treatment. The company's current clinical programs include Phase 2 studies of fostamatinib in autoimmune hemolytic anemia and IgA nephropathy, and a Phase 1 study for its IRAK program. In addition, Rigel Pharmaceuticals has product candidates in development with partners BerGenBio AS, Daiichi Sankyo, and Aclaris Therapeutics. Since inception, Rigel Pharmaceuticals h...

Silicon Investor Message Boards

This table lists all message boards related to ASX:EAR / ECHO RESOURCES LIMITED on message board site Silicon Investor.

Heart Attacks, Cancer and strokes. Preventative approaches Heart Attacks, Cancer and strokes. Preventative approaches Heart Attacks, Cancer and strokes. Preventative approaches Anthony @ Equity Investigations, Dear Anthony, Anthony @ Equity Investigations, Dear Anthony, Anthony @ Equity Investigations, Dear Anthony,
Research Frontiers (REFR) Research Frontiers (REFR) Research Frontiers (REFR) Rare Earth Elements and Exotic Metals Rare Earth Elements and Exotic Metals Rare Earth Elements and Exotic Metals
Smartphones, Tablets, Wearables and Gadgets Smartphones, Tablets, Wearables and Gadgets Smartphones, Tablets, Wearables and Gadgets Computer Learning Computer Learning Computer Learning
Research Frontiers Lonely Hearts Club Thread. Research Frontiers Lonely Hearts Club Thread. Research Frontiers Lonely Hearts Club Thread. Chicago Bears Fan Club Chicago Bears Fan Club Chicago Bears Fan Club
Sears Holdings Corp. Sears Holdings Corp. Sears Holdings Corp. BB: BlackBerry (fka RIMM: Research in Motion) BB: BlackBerry (fka RIMM: Research in Motion) BB: BlackBerry (fka RIMM: Research in Motion)